HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MIDAS syndrome (microphthalmia, dermal aplasia, and sclerocornea): an X-linked phenotype distinct from Goltz syndrome.

Abstract
Bilateral microphthalmia with blepharophimosis, linear lesions of dermal aplasia involving the face, and microcephaly were present in a newborn girl who died at age 9 months from cardiomyopathy resulting in ventricular fibrillation. Autopsy showed an atrial septum defect, persistent gross trabeculation of the left ventricle, and an arteria lusoria. This case represents a further example of a new entity for which we propose the term MIDAS syndrome. The acronym stands for microphthalmia, dermal aplasia, and sclerocornea. Our patient is the second with this syndrome to have a major congenital heart defect. Cytogenetic studies reported in previous cases indicate that the underlying gene defect can be assigned to Xp22.3. This new X-linked male-lethal trait should be distinguished from focal dermal hypoplasia that will be found to map elsewhere on the X-chromosome.
AuthorsR Happle, O Daniëls, R J Koopman
JournalAmerican journal of medical genetics (Am J Med Genet) Vol. 47 Issue 5 Pg. 710-3 (Oct 01 1993) ISSN: 0148-7299 [Print] United States
PMID8267001 (Publication Type: Case Reports, Comparative Study, Journal Article, Review)
Topics
  • Abnormalities, Multiple (genetics)
  • Corneal Opacity (genetics)
  • Female
  • Focal Dermal Hypoplasia (diagnosis, genetics)
  • Genetic Linkage
  • Humans
  • Infant
  • Microphthalmos (genetics)
  • Phenotype
  • Skin Abnormalities
  • Syndrome
  • X Chromosome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: